Century Therapeutics, Inc. is a leading pharmaceutical company based in the United States. With an ESG score of 27.5, they are considered a medium-risk company in the industry. Specializing in the use of adult stem cells, Century Therapeutics focuses on developing advanced cell therapy products for cancer, autoimmune, and inflammatory diseases. Their innovative approach includes utilizing induced pluripotent stem cells (iPSCs), CRISPR-mediated gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to enhance cell product performance, reduce rejection by the immune system, and minimize development and supply risks.